Citation Impact
Citing Papers
Lamivudine for chronic delta hepatitis
1999
IgG4-associated ampullitis and cholangiopathy in Crohn's disease
2011
Preliminary clinical study of the distribution of HPMA copolymers bearing doxorubicin and galactosamine
1999
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies
2005 Standout
Syndemics and the biosocial conception of health
2017 Standout
Liver fibrosis
2005 Standout
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Hepatitis D virus: an update
2010
Burden of liver diseases in the world
2018 Standout
Hepatitis B and Hepatitis C Viruses in Liver Transplantation
2004
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
2013 Standout
Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative.
1996 Standout
Management of Congenital Bile Duct Cysts
2010
Extended HBV vaccination in liver transplant recipients for HBV-related cirrhosis: Report of two successful cases
2005
Functions of the Fibrinolytic System in Human Ito Cells and Its Control by Basic Fibroblast and Platelet–Derived Growth Factor
1999
Contrast agents in magnetic resonance imaging of the liver: Present and future
1998
Nanoparticle therapeutics: an emerging treatment modality for cancer
2008 Standout
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
Hepatitis delta virus
2011
Drug-Induced Hepatotoxicity
2003 Standout
Hepatic MRI with SPIO: detection and characterization of focal liver lesions
1998
Pancreatic cancer
2016 Standout
Pharmacokinetics, Metabolism, and Carcinogenicity of Arsenic
2001
Usefulness of 18F-FDG PET, combined FDG-PET/CT and EUS in diagnosing primary pancreatic carcinoma: A meta-analysis
2009
FDG-PET in diagnosis, staging and prognosis of pancreatic carcinoma: A meta-analysis
2013
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Immunoglobulin G4–Associated Cholangitis: Clinical Profile and Response to Therapy
2008 Standout
Management of Hepatocellular Carcinoma *
2005 Standout
Liver transplantation for chronic viral hepatitis
1995
To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery
2010 Standout
Utility of serum CA19-9 in diagnosis of cholangiocarcinoma: In comparison with CEA
2004
Polymer conjugates as anticancer nanomedicines
2006 Standout
Epigallocatechin-3-gallate (EGCG) reduces liver inflammation, oxidative stress and fibrosis in carbon tetrachloride (CCl4)-induced liver injury in mice
2010
Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury
2000 Standout
Mechanisms of Hepatic Fibrogenesis
2008 Standout
The Myofibroblastic Conversion of Peribiliary Fibrogenic Cells Distinct from Hepatic Stellate Cells Is Stimulated by Platelet-Derived Growth Factor During Liver Fibrogenesis
2003
Chronic hepatitis B
2007 Standout
Outcomes of patients with chest tube insertion for hepatic hydrothorax
2009
Magnetic nanoparticles in MR imaging and drug delivery
2008 Standout
Risk Factors, Clinical Characteristics, and Outcome of Nocardia Infection in Organ Transplant Recipients: A Matched Case-Control Study
2007 Standout
Chronic hepatitis B: Update 2009 #
2009 Standout
Strategies in the design of nanoparticles for therapeutic applications
2010 Standout
Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications
2003
Hepatoprotective effects of Yulangsan polysaccharide against nimesulide-induced liver injury in mice
2015
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
2014 Standout
Lanreotide Reduces the Volume of Polycystic Liver: A Randomized, Double-Blind, Placebo-Controlled Trial
2009
The Spectrum of Portal Vein Thrombosis in Liver Transplantation
1991
IgG4-related disease
2014 Standout
Hypervitaminosis A‐induced liver fibrosis: stellate cell activation and daily dose consumption
2005
Hepatic Hydrothorax
2014
Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR)
2012 Standout
Increased ADAMTS‐13 proteolytic activity in rat hepatic stellate cells upon activation in vitro and in vivo
2006
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Amoxicillin–Clavulanate-Induced Liver Injury
2016
Smads 2 and 3 Are Differentially Activated by Transforming Growth Factor-β (TGF-β) in Quiescent and Activated Hepatic Stellate Cells
2003
Conditional Tetracycline–Regulated Expression of Tgf–β1 in Liver of Transgenic Mice Leads to Reversible Intermediary Fibrosis
2003
Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
2012 Standout
Transjugular intrahepatic portosystemic stent shunt for medically refractory hepatic hydrothorax: A systematic review and cumulative meta-analysis
2015
Infection in Solid-Organ Transplant Recipients
2007 Standout
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
2001 Standout
The P450 Superfamily: Update on New Sequences, Gene Mapping, and Recommended Nomenclature
1991
Liver transplantation for hepatitis B virus-related liver disease: Indications, prevention of recurrence and results
2003
Psychopharmacologic Treatment of Depression in the Medically Ill
1998
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Anti‐oxidant ebselen causes the resolution of experimentally induced hepatic fibrosis in rats
2001
Revising consensus in portal hypertension: Report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension
2010 Standout
The dawning era of polymer therapeutics
2003 Standout
Universal precautions prevent hepatitis C virus transmission: A 54 month follow-up of the Belgian multicenter study
1998
All- trans and 9- cis retinoic acid alter rat hepatic stellate cell phenotype differentially
1999
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
TGF‐β signaling and the fibrotic response
2004 Standout
Therapeutic Nanoparticles for Drug Delivery in Cancer
2008 Standout
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
2018 Standout
Acupuncture: Theory, Efficacy, and Practice
2002 Standout
Infections in solid-organ transplant recipients
1997
Infectious Diseases Society of America Guidelines for the Diagnosis and Treatment of Asymptomatic Bacteriuria in Adults
2005 Standout
In Vitro Nimesulide Studies toward Understanding Idiosyncratic Hepatotoxicity: Diiminoquinone Formation and Conjugation
2008
The Many Roles for Fluorine in Medicinal Chemistry
2008 Standout
Prognostic value of the aminopyrine breath test in cirrhotic patients
1986
Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta-analysis
2021
Management of the hepatitis B virus in the liver transplantation setting: A European and an American perspective
2005
Hepatic Drug Targeting: Phase I Evaluation of Polymer-Bound Doxorubicin
2002
The Ecology of Arsenic
2003 StandoutScience
Aspergillus fumigatusand Aspergillosis
1999 Standout
The Role of Oxidative Stress and Antioxidants in Liver Diseases
2015 Standout
Complications of Acupuncture
1995
Is alanine aminotransferase a good marker of histologic hepatic damage in renal transplant patients with hepatitis C virus infection?
2005
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Quantitative liver function in the elderly assessed by galactose elimination capacity, aminopyrine demethylation and caffeine clearance
1986
Idiosyncratic Drug Reactions: Current Understanding
2006
Mechanism of Oxidation Reactions Catalyzed by Cytochrome P450 Enzymes
2004 Standout
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Magnetic nanoparticle design for medical diagnosis and therapy
2004 Standout
Structural Alert/Reactive Metabolite Concept as Applied in Medicinal Chemistry to Mitigate the Risk of Idiosyncratic Drug Toxicity: A Perspective Based on the Critical Examination of Trends in the Top 200 Drugs Marketed in the United States
2011
Recommendations for the Outpatient Surveillance of Renal Transplant Recipients
2000
Organoselenium and Organotellurium Compounds: Toxicology and Pharmacology
2004 Standout
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
2011 Standout
Works of André Geubel being referenced
Pilotage des anthracyclines et hépatomes.
1987
Preoperative assessment of pancreatic tumors using magnetic resonance imaging, endoscopic ultrasonography, positron emission tomography and laparoscopy
2005
Patterns of hepatitis delta virus reinfection and disease in liver transplantation
1991
Ulcerative colitis associated with IgG4 cholangitis: Similar features in two HLA identical siblings
2009
Liver transplantation for nonsteroidal anti-inflammatory drug-induced liver failure: nimesulide as the first implicated compound
2007
Immunoquantification of cytochrome P‐450 3A on rat paraffin‐embedded liver tissue
1992
Case Report: Hepatobiliary Cystadenocarcinoma Without Ovarian Stroma and Normal CA 19-9 Levels (Unusually Prolonged Evolution)
1997
Adult Polycystic Liver Disease
1997
Outcome of HCV infection after renal transplantation
1994
Liver injury related to amoxycillin-clavulanic acid: interlobular bile-duct lesions and extrahepatic manifestations
1995
HLA association of amoxicillin-clavulanate–induced hepatitis
1999
Liver transplantation and HBsAg-positive postnecrotic cirrhosis: adequate immunoprophylaxis and delta virus co-infection as the significant determinants of long-term prognosis
1999
Increased hepatocytic mitotic activity as a diagnostic marker of acute arsenic intoxication
1996
Vitamin A abuse: development of cirrhosis despite cessation of vitamin A. A six‐year clinical and histopathologic follow‐up
1992
The place of liver transplantation in Caroli's disease and syndrome
2006
Favorable outcome of orthotopic liver transplantation in a patient with subacute liver failure due to the emergence of a hepatitis B YMDD escape mutant virus
2001
Arterialization of the Portal Vein in Conjunction with a Therapeutic Portacaval Shunt Hemodynamic Investigations and Results in 75 Patients
1982
Benign Hepatocellular Tumors
1995
Breath14CO2 after intravenous administration of [14C]aminopyrine in liver diseases
1982
[Arterialization of the portal vein. Preliminary results of a prospective randomized study].
1984
[Hepatitis B due to acupuncture. Report of 7 cases].
1983
The outcome after transjugular intrahepatic portosystemic shunt (TIPS) for hepatic hydrothorax is closely related to liver dysfunction: a long-term study in 28 patients.
2007